AMLX

NASDAQ · Equity

Amylyx Pharmaceuticals Inc

US Healthcare Drug Manufacturers - Specialty & Generic

Latest week: 29 May 2026
Close: 14.350000
Fair value: 10.045737
Expectation: Negative 41.14%

Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending: 29 May 2026
Latest Close: 14.35
12-Week Change: 2.57%
Trend Signal: Inactive
Expectation: Negative 41.14%
Signal Weeks: 11 of 12
Vs Trend Line: Above
Vs Fair Value: Above
Relative Strength: -3.91
Market Dynamics: -0.62

Over the latest 12 completed weeks ending 2026-05-29, AMLX rose 2.57%, moving from 13.99 to 14.35. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 11 of the last 12 weeks. Relative Strength is -3.91 and has softened across the 12-week window. Market Dynamics is -0.62 on the latest week. Expectation is negative at 41.14%.